Ulcerative dermatosis of the Shetland sheepdog and rough collie dog may represent a novel vesicular variant of cutaneous lupus erythematosus
Jackson HA, Olivry T. Ulcerative dermatosis of the Shetland sheepdog and rough collie dog may represent a novel vesicular variant of cutaneous lupus erythematosus. Vet Dermatol 2001; 12: 19-27.
Immunopathology of vesicular cutaneous lupus erythematosus in the rough collie and Shetland sheepdog: a canine homologue of subacute cutaneous lupus erythematosus in humans
Jackson HA, Olivry T, Berget F et al. Immunopathology of vesicular cutaneous lupus erythematosus in the rough collie and Shetland sheepdog: a canine homologue of subacute cutaneous lupus erythematosus in humans. Vet Dermatol 2004; 15: 230-239.
Eleven cases of vesicular cutaneous lupus erythematosus in Shetland sheepdogs and rough collies: clinical management and prognosis
Jackson HA. Eleven cases of vesicular cutaneous lupus erythematosus in Shetland sheepdogs and rough collies: clinical management and prognosis. Vet Dermatol 2004; 15: 37-41.
Treatment with oral cyclosporin A of a case of vesicular cutaneous lupus erythematosus in a rough collie
Font A, Bardagi M, Mascort J et al. Treatment with oral cyclosporin A of a case of vesicular cutaneous lupus erythematosus in a rough collie. Vet Dermatol 2006; 17: 440-442.
Topical 0.1% tacrolimus for the treatment of discoid lupus erythematosus and pemphigus erythematosus in dogs
Griffies JD, Mendelsohn CL, Rosenkrantz WS et al. Topical 0.1% tacrolimus for the treatment of discoid lupus erythematosus and pemphigus erythematosus in dogs. J Am Anim Hosp Assoc 2003; 15: 1-13.
Use of tetracycline and niacinamide for treatment of autoimmune skin disease in 31 dogs
White SD, Rosychuck RA, Reinke SL et al. Use of tetracycline and niacinamide for treatment of autoimmune skin disease in 31 dogs. J Am Vet Med Assoc 1992; 200: 1497-1500.
Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: an evidence-based evaluation
Tzellos TG, Kouvelas D. Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: an evidence-based evaluation. Eur J Clin Pharmacol 2007; 64: 337-341.